Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(5):358-368; doi:10.1093/jnci/94.5.358
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kitanaka, C.
Right arrow Articles by Kuchino, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitanaka, C.
Right arrow Articles by Kuchino, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 5, 358-368, March 6, 2002
© 2002 Oxford University Press


ARTICLE

Increased Ras Expression and Caspase-Independent Neuroblastoma Cell Death: Possible Mechanism of Spontaneous Neuroblastoma Regression

Chifumi Kitanaka, Keisuke Kato, Rieko Ijiri, Kaori Sakurada, Arata Tomiyama, Kohji Noguchi, Yohji Nagashima, Akira Nakagawara, Takashi Momoi, Yasunori Toyoda, Hisato Kigasawa, Toshiji Nishi, Mikako Shirouzu, Shigeyuki Yokoyama, Yukichi Tanaka, Yoshiyuki Kuchino

Affiliations of authors: C. Kitanaka, K. Sakurada, A. Tomiyama, K. Noguchi, Y. Kuchino, Biophysics Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan; K. Kato, R. Ijiri, Y. Tanaka (Division of Pathology), Y. Toyoda (Division of Oncology), H. Kigasawa (Division of Hematology), T. Nishi (Division of Surgery), Kanagawa Children's Medical Center, Minami-ku, Yokohama, Japan; Y. Nagashima, Second Department of Pathology, School of Medicine, Yokohama City University, Kanazawa-ku, Yokohama; A. Nakagawara, Division of Biochemistry, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba, Japan; T. Momoi, Division of Development and Differentiation, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo; M. Shirouzu, S. Yokoyama, Genomic Sciences Center, RIKEN Yokohama Institute, Tsurumi, Yokohama; S. Yokoyama, Department of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, Bunkyo-ku, Tokyo; Y. Kuchino, Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Kawaguchi, Saitama, Japan.

Correspondence to: C. Kitanaka, M.D., or Y. Kuchino, Ph.D., Biophysics Division, National Cancer Center Research Institute, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan (e-mail: ckitanak{at}ncc.go.jp).

Background: Neuroblastoma undergoes spontaneous regression frequently during its natural course. Although programmed cell death (PCD) has been implicated in this process, accumulating evidence suggests that apoptosis, a form of PCD that is regulated by caspases, may not play a major role. We examined the mechanism(s) of spontaneous regression of neuroblastoma, focusing on the role of Ras, a favorable prognostic marker of neuroblastoma. Methods: Tumor tissues were analyzed by light microscopy, electron microscopy, and immunohistochemistry to examine cell degeneration and expression of Ras and several indicators of PCD. Cell degeneration was also studied in vitro in neuroblastoma cells transfected with the H-ras gene. All statistical tests were two-sided. Results: Immunohistochemical analyses revealed that Ras expression was increased in areas of cellular degeneration lacking apoptotic characteristics. The degenerating cells were fragmented without nuclear condensation and, essentially, lacked caspase-3 activation and apoptotic DNA fragmentation. These cells had ultrastructural features of autophagic degeneration, another form of PCD that is distinct from apoptosis. Focal areas of degeneration associated with Ras expression were seen more frequently in tumors from patients detected in a mass-screening program (53 [60.9%] of 87) than in tumors from clinically detected, advanced-stage patients over 1 year of age (7 [29.2%] of 24) (P = .006; chi-square test), suggesting a positive relationship between Ras-associated degeneration and probability of spontaneous regression/favorable prognosis. The characteristic features of Ras-associated nonapoptotic degeneration observed in tumor samples were recapitulated in vitro by transfection-mediated Ras expression, and Ras-mediated degeneration was augmented by TrkA, another favorable prognostic marker. Conclusions: High-level expression of H-Ras in neuroblastoma cells is associated with caspase cascade-independent, nonapoptotic PCD. This Ras-mediated nonapoptotic tumor cell death may play a key role in spontaneous regression of neuroblastoma.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
W.-M. Hsu, H. Lee, H.-F. Juan, Y.-Y. Shih, B.-J. Wang, C.-Y. Pan, Y.-M. Jeng, H.-H. Chang, M.-Y. Lu, K.-H. Lin, et al.
Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis
Clin. Cancer Res., October 1, 2008; 14(19): 6237 - 6245.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Singletary and J. Milner
Diet, Autophagy, and Cancer: A Review
Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1596 - 1610.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. De Geer, R. Kiessling, V. Levitsky, and J. Levitskaya
Cytotoxic T Lymphocytes Induce Caspase-Dependent and -Independent Cell Death in Neuroblastomas in a MHC-Nonrestricted Fashion
J. Immunol., December 1, 2006; 177(11): 7540 - 7550.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Fischer, A. Oberthuer, B. Brors, Y. Kahlert, M. Skowron, H. Voth, P. Warnat, K. Ernestus, B. Hero, and F. Berthold
Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome
Clin. Cancer Res., September 1, 2006; 12(17): 5118 - 5128.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
R. Radl, A. Leithner, N. Kastner, K. Bodo, A. Nader, and R. Windhager
Disappearance of a Cervical Spine Chordoma After Nonoperative Treatment. A Case Report
J. Bone Joint Surg. Am., August 1, 2005; 87(8): 1822 - 1827.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
B. L. Schneider and M. Kulesz-Martin
Destructive cycles: the role of genomic instability and adaptation in carcinogenesis
Carcinogenesis, November 1, 2004; 25(11): 2033 - 2044.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. M. Gillanders, J. Xu, B.-l. Chang, E. M. Lange, F. Wiklund, J. E. Bailey-Wilson, A. Baffoe-Bonnie, M. Jones, D. Gildea, E. Riedesel, et al.
Combined Genome-Wide Scan for Prostate Cancer Susceptibility Genes
J Natl Cancer Inst, August 18, 2004; 96(16): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
D. M. Elston
Mechanisms of Regression
Clin. Med. Res., May 1, 2004; 2(2): 85 - 88.
[Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Takiguchi, N. Sugino, K. Esato, A. Karube-Harada, A. Sakata, Y. Nakamura, H. Ishikawa, and H. Kato
Differential Regulation of Apoptosis in the Corpus Luteum of Pregnancy and Newly Formed Corpus Luteum after Parturition in Rats
Biol Reprod, February 1, 2004; 70(2): 313 - 318.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. P. Reynolds
Ras and Seppuku in Neuroblastoma
J Natl Cancer Inst, March 6, 2002; 94(5): 319 - 321.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.